U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07548606) titled 'A Drug-Drug Interaction Study of Itraconazole and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-017)' on April 17.
Brief Summary: Researchers have designed a study medicine called opevesostat as a new way to treat prostate cancer.
The purpose of this study is to learn what happens to opevesostat in a person's body over time (a pharmacokinetic or PK study). Researchers will compare what happens to opevesostat in the body when it is given with and without another medicine called itraconazole.
Study Start Date: May 04
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Opevesostat
Administered...